157 related articles for article (PubMed ID: 19900229)
1. Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks.
Onat A; Hergenç G; Ayhan E; Uğur M; Kaya H; Tuncer M; Can G
Diabet Med; 2009 Oct; 26(10):981-8. PubMed ID: 19900229
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk.
Aroner SA; Yang M; Li J; Furtado JD; Sacks FM; Tjønneland A; Overvad K; Cai T; Jensen MK
Am J Epidemiol; 2017 Sep; 186(6):736-744. PubMed ID: 28520887
[TBL] [Abstract][Full Text] [Related]
4. High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.
Yamamoto R; Sacks FM; Hu FB; Rosner B; Furtado JD; Aroner SA; Ferrannini E; Baldi S; Kozakova M; Balkau B; Natali A; Jensen MK;
Atherosclerosis; 2018 Feb; 269():92-99. PubMed ID: 29351856
[TBL] [Abstract][Full Text] [Related]
5. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
[TBL] [Abstract][Full Text] [Related]
6. Serum total and high-density lipoprotein phospholipids: independent predictive value for cardiometabolic risk.
Onat A; Altuğ Çakmak H; Can G; Yüksel M; Köroğlu B; Yüksel H
Clin Nutr; 2014 Oct; 33(5):815-22. PubMed ID: 24246837
[TBL] [Abstract][Full Text] [Related]
7. High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis).
Aroner SA; Koch M; Mukamal KJ; Furtado JD; Stein JH; Tattersall MC; McClelland RL; Jensen MK
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29540426
[TBL] [Abstract][Full Text] [Related]
8. Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks.
Onat A; Hergenç G; Ayhan E; Uğur M; Can G
Clin Chem Lab Med; 2009; 47(11):1389-94. PubMed ID: 19817643
[TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.
Wang W; Khan S; Blackett P; Alaupovic P; Lee E
J Clin Lipidol; 2013; 7(1):38-42. PubMed ID: 23351581
[TBL] [Abstract][Full Text] [Related]
10. High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts.
Jensen MK; Aroner SA; Mukamal KJ; Furtado JD; Post WS; Tsai MY; Tjønneland A; Polak JF; Rimm EB; Overvad K; McClelland RL; Sacks FM
Circulation; 2018 Mar; 137(13):1364-1373. PubMed ID: 29162611
[TBL] [Abstract][Full Text] [Related]
11. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
Onat A; Hergenç G; Can G; Uğur M; Nartop F
Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
Aroner SA; Furtado JD; Sacks FM; Tsai MY; Mukamal KJ; McClelland RL; Jensen MK
Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
[TBL] [Abstract][Full Text] [Related]
13. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.
Mendivil CO; Rimm EB; Furtado J; Sacks FM
J Am Heart Assoc; 2013 May; 2(3):e000130. PubMed ID: 23672999
[TBL] [Abstract][Full Text] [Related]
15. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.
Talayero B; Wang L; Furtado J; Carey VJ; Bray GA; Sacks FM
J Lipid Res; 2014 Oct; 55(10):2167-77. PubMed ID: 24966274
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
[TBL] [Abstract][Full Text] [Related]
17. High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones.
Onat A; Can G; Hergenç G; Küçükdurmaz Z; Uğur M; Yüksel H
Cardiology; 2010; 115(4):297-306. PubMed ID: 20395681
[TBL] [Abstract][Full Text] [Related]
18. Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III.
Koch M; Furtado JD; Jiang GZ; Gray BE; Cai T; Sacks F; Tjønneland A; Overvad K; Jensen MK
J Lipid Res; 2017 Jun; 58(6):1196-1203. PubMed ID: 28365588
[TBL] [Abstract][Full Text] [Related]
19. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
[TBL] [Abstract][Full Text] [Related]
20. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
